↓ Skip to main content

Dove Medical Press

Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
98 Mendeley
Title
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
Published in
Therapeutics and Clinical Risk Management, June 2012
DOI 10.2147/tcrm.s24239
Pubmed ID
Authors

Athanasios D Anastasilakis, Konstantinos A Toulis, Stergios A Polyzos, Chrysostomos D Anastasilakis, Polyzois Makras

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Gambia 1 1%
Unknown 96 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 19 19%
Student > Master 16 16%
Researcher 11 11%
Student > Bachelor 9 9%
Other 9 9%
Other 19 19%
Unknown 15 15%
Readers by discipline Count As %
Medicine and Dentistry 47 48%
Biochemistry, Genetics and Molecular Biology 6 6%
Chemistry 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Nursing and Health Professions 3 3%
Other 11 11%
Unknown 21 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2016.
All research outputs
#15,757,907
of 25,728,855 outputs
Outputs from Therapeutics and Clinical Risk Management
#698
of 1,325 outputs
Outputs of similar age
#106,514
of 179,795 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#5
of 11 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,325 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,795 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.